Category: Uncategorized

A research overview of Semax: its heptapeptide structure, the BDNF-focused preclinical literature, and what to check on a certificate of analysis.

A research overview of Epithalon (epitalon, AEDG): its origin in pineal peptide research, the telomerase literature, and how to verify lot purity.

What separates CJC-1295 with DAC from the no-DAC form, how the Drug Affinity Complex changes stability, and what a quality lot looks like on paper.

BPC-157 and TB-500 come from unrelated proteins and act through unrelated mechanisms. A side-by-side look at their origins, mechanisms, research literatures, and when a study design calls for one, the other, or both.

Tirzepatide (LY3298176) is a 39-amino-acid peptide that activates both GIP and GLP-1 receptors. How it works, its structure, half-life, approvals and how it compares with semaglutide.

Semaglutide is the reference GLP-1 receptor research peptide. What the acylated analog is, why the fatty-acid modification matters for handling, and how researchers verify material.

Ipamorelin is a five-residue growth-hormone secretagogue prized in research for receptor selectivity. Structure, how it differs from GHRP-2/GHRP-6, handling, and lot verification.

Tesamorelin is a 44-residue GHRH analog with a stabilizing N-terminal modification. What differentiates it from other GHRH-pathway peptides, plus storage behavior and quality checks.

TB-500 is the actin-binding fragment of thymosin β4 studied in tissue-repair models. Structure, handling, how it differs from full-length Tβ4, and the quality checks that matter.

Retatrutide (LY3437943) is an investigational peptide that activates GIP, GLP-1 and glucagon receptors. What it is, how it works, its structure, half-life, trial results and FDA status.